Page last updated: 2024-10-21

isocitric acid and Lewy Body Disease

isocitric acid has been researched along with Lewy Body Disease in 1 studies

isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jaramillo-Jimenez, A1
Giil, LM1
Borda, MG1
Tovar-Rios, DA1
Kristiansen, KA1
Bruheim, P1
Aarsland, D1
Barreto, GE1
Berge, RK1

Other Studies

1 other study available for isocitric acid and Lewy Body Disease

ArticleYear
Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis.
    Mitochondrion, 2023, Volume: 71

    Topics: Alzheimer Disease; Apolipoproteins E; Carboxylic Acids; Cognition; Dementia; Humans; Isocitrates; Le

2023